يعرض 71 - 80 نتائج من 373 نتيجة بحث عن '"Lauren Averett Byers"', وقت الاستعلام: 1.34s تنقيح النتائج
  1. 71
    Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

    المؤلفون: Neda Kalhor, Vali Papadimitrakopoulou, Don L. Gibbons, Luyang Yao, Melenda Jeter, Ferdinandos Skoulidis, John V. Heymach, Charles Lu, Daniel R. Gomez, Lauren Averett Byers, Jonathan M. Kurie, Joe Y. Chang, Frank V. Fossella, George R. Blumenschein, Mehmet Altan, Michael S. O'Reilly, Anne S. Tsao, Yan Lin, Brett W. Carter, Zhongxing Liao, Peter F. Thall, Steven H. Lin, George R. Simon

    المصدر: Journal of Thoracic Oncology. 15:248-257

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Durvalumab, Locally advanced, Phases of clinical research, Antibodies, Monoclonal, Humanized, Cancer recurrence, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Adverse effect, Pneumonitis, business.industry, Consolidation Chemotherapy, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd52a5faec63f5ca6d70835c88d9f806Test
    https://doi.org/10.1016/j.jtho.2019.10.024Test


    أضف إلى المفضلة
  2. 72
    MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer

    المؤلفون: Carina Lorenz, John T. Poirier, Lauren Averett Byers, Jeremy Ryan, Marcel A. Dammert, Annika Marx, Roman K. Thomas, Johannes Brägelmann, Matthew R. Guthrie, Hannah L. Tumbrink, Reinhard Büttner, Triparna Sen, Ron D. Jachimowicz, Christopher P. Whitney, Niloufar Monhasery, Anna Schmitt, Rachelle R. Olsen, Milind D. Chalishazar, Trudy G. Oliver, Elmar Wolf, Sebastian Klein, Roberta Castiglione, Stefanie Böhm, Anthony Letai, Luka Ozretić, Abbie S. Ireland, H. Christian Reinhardt, Martin L. Sos

    المصدر: Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
    Nat Commun
    Nature Communications

    مصطلحات موضوعية: 0301 basic medicine, Lung Neoplasms, animal structures, Science, General Physics and Astronomy, Priming (immunology), Antineoplastic Agents, Apoptosis, 02 engineering and technology, Biology, Article, Small-cell lung cancer, General Biochemistry, Genetics and Molecular Biology, Proto-Oncogene Proteins c-myc, Mice, 03 medical and health sciences, Targeted therapies, Transcription (biology), Cell Line, Tumor, Animals, Humans, MCL1, Molecular Targeted Therapy, RNA, Small Interfering, lcsh:Science, neoplasms, Regulation of gene expression, Multidisciplinary, HEK 293 cells, Combination chemotherapy, Oncogenes, General Chemistry, G2-M DNA damage checkpoint, 021001 nanoscience & nanotechnology, Small Cell Lung Carcinoma, 3. Good health, Gene Expression Regulation, Neoplastic, Disease Models, Animal, HEK293 Cells, 030104 developmental biology, Genetic engineering, Cancer research, lcsh:Q, CRISPR-Cas Systems, 0210 nano-technology, DNA Damage

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::502624be3e17351db82cdd17209c43acTest
    http://link.springer.com/article/10.1038/s41467-019-11371-xTest


    أضف إلى المفضلة
  3. 73
    Immunogenomic Intertumor Heterogeneity Across Primary and Metastatic Sites in a Patient With Lung Adenocarcinoma

    المؤلفون: Carmen Behrens, Peixin Jiang, Curtis Gumbs, John V. Heymach, Ignacio I. Wistuba, Jun Li, Xingzhi Song, Alexandre Reuben, Don L. Gibbons, Runzhe Chen, Chi-Wan Chow, Latasha Little, Dongfeng Tan, Xin Hu, Jianhua Zhang, Kelly Quek, Akash Mitra, P. Andrew Futreal, Lauren Averett Byers, Junya Fujimoto, Jianjun Zhang, Ming Tang

    مصطلحات موضوعية: Mutation, T cell, T-cell receptor, Methylation, Biology, medicine.disease_cause, medicine.disease, medicine.anatomical_structure, DNA methylation, medicine, Cancer research, Adenocarcinoma, Lung cancer, Epigenomics

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3113ff2ae132b369d23fd4542f9964dTest
    https://doi.org/10.21203/rs.3.rs-970663/v1Test


    أضف إلى المفضلة
  4. 74
    Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study

    المؤلفون: Suresh S. Ramalingam, Lei He, Mária Szilasi, Martin Dunbar, Bruce A. Bach, Ramaswamy Govindan, Julien Mazieres, Silvia Novello, R. Bernabé, Xin Huang, Everett E. Vokes, Peter Ansell, Salih Zeki Guclu, Dmitry Bentsion, Philip Clingan, Zanete Zvirbule, Jair Bar, Vasudha Sehgal, Konstantinos N. Syrigos, Jaimee Glasgow, Lauren Averett Byers

    المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(32)

    مصطلحات موضوعية: Adult, Male, Cancer Research, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Benzimidazoles, Biomarkers, Tumor, Carboplatin, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Clinical Decision-Making, Female, Gene Expression Profiling, Humans, Lung Neoplasms, Middle Aged, Neoplasm Staging, Paclitaxel, Patient Selection, Progression-Free Survival, Smokers, Time Factors, Transcriptome, Veliparib, DNA damage, medicine.medical_treatment, Squamous cell lung cancer, chemistry.chemical_compound, 80 and over, Medicine, Lung cancer, Non-Small-Cell Lung, Polymerase, Chemotherapy, Tumor, biology, business.industry, Carcinoma, medicine.disease, First line treatment, Oncology, chemistry, Squamous Cell, biology.protein, Cancer research, business, Biomarkers

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514dc6ffd32107af8c370ecf50e3b82fTest
    https://pubmed.ncbi.nlm.nih.gov/34436928Test


    أضف إلى المفضلة
  5. 75
    Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

    المؤلفون: C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson, Simon Heeke, Elizabeth M. Park, Samrat T. Kundu, Lixia Diao, Qi Wang, Li Shen, Yuanxin Xi, Bingnan Zhang, Carminia Maria Della Corte, Youhong Fan, Kiran Kundu, Boning Gao, Kimberley Avila, Curtis R. Pickering, Faye M. Johnson, Jianjun Zhang, Humam Kadara, John D. Minna, Don L. Gibbons, Jing Wang, John V. Heymach, Lauren Averett Byers

    المساهمون: Stewart, C. A., Gay, C. M., Ramkumar, K., Cargill, K. R., Cardnell, R. J., Nilsson, M. B., Heeke, S., Park, E. M., Kundu, S. T., Diao, L., Wang, Q., Shen, L., Xi, Y., Zhang, B., Della Corte, C. M., Fan, Y., Kundu, K., Gao, B., Avila, K., Pickering, C. R., Johnson, F. M., Zhang, J., Kadara, H., Minna, J. D., Gibbons, D. L., Wang, J., Heymach, J. V., Byers, L. A.

    المصدر: Journal of Thoracic Oncology

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Coronavirus disease 2019 (COVID-19), viruses, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Population, ACE2, Bronchi, Peptidyl-Dipeptidase A, NSCLC, Pathogenesis, Internal medicine, medicine, Humans, ZEB1, Epithelial–mesenchymal transition, Respiratory system, education, Lung cancer, Lung, Psychological repression, Cell entry, education.field_of_study, SARS-CoV-2, business.industry, Mesenchymal stem cell, EMT, AXL, COVID-19, Cancer, medicine.disease, Editorial, medicine.anatomical_structure, Viral Receptor, Cancer research, Original Article, business, Bristol-Myers, Human

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b8d743fb52bdefabd4cd379d833ba0Test
    http://europepmc.org/articles/PMC8282443Test


    أضف إلى المفضلة
  6. 76
    A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)

    المؤلفون: Ding Wang, Bryan A. Faller, Lauren Averett Byers, Ronald H. Yanagihara, Roy H. Decker, Allen M. Chen, Scott N. Gettinger, Mihaela C. Cristea, Karen Kelly, Mary W. Redman, Linda L. Garland, Kathy S. Albain, Megan E. Daly, David R. Gandara, Jacob Sands, Marianna Koczywas, Athanassios Argiris, Jieling Miao

    المصدر: Clinical lung cancer, vol 22, iss 4
    Clin Lung Cancer

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Placebo-controlled study, NSCLC, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Non-Small-Cell Lung, PARP inhibitors, Lung, Cancer, Aged, 80 and over, Lung Cancer, Chemoradiotherapy, Middle Aged, Progression-Free Survival, 6.5 Radiotherapy and other non-invasive therapies, Survival Rate, Paclitaxel, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, PARP inhibitor, Female, Drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Veliparib, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Placebo, Article, Dose-Response Relationship, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Lung cancer, Neoplasm Staging, Aged, Dose-Response Relationship, Drug, business.industry, Carcinoma, Evaluation of treatments and therapeutic interventions, medicine.disease, 030104 developmental biology, Orphan Drug, chemistry, Benzimidazoles, business, Thoracic radiotherapy

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393a26ccbd48bf1e54aabad205028d60Test
    https://escholarship.org/uc/item/8xv6h4ffTest


    أضف إلى المفضلة
  7. 77
    SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmonary small cell neuroendocrine carcinomas (NEC)

    المؤلفون: David Bing Zhen, Edward Mayerson, E. Gabriela Chiorean, Earle F Burgess, Elizabeth M. Swisher, Carl Michael Gay, Lauren Averett Byers, Ignacio Ivan Wistuba, Haider Mahdi, Satya Das, Jason S. Starr, Megan Othus, Young Kwang Chae, Razelle Kurzrock

    المصدر: Journal of Clinical Oncology. 40:TPS4179-TPS4179

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ca617a1f918c31e7d352ddc2605fb248Test
    https://doi.org/10.1200/jco.2022.40.16_suppl.tps4179Test


    أضف إلى المفضلة
  8. 78
    Results of a phase 1b study of osimertinib plus sapanisertib or alisertib for osimertinib-resistant, EGFR-mutant non–small cell lung cancer (NSCLC)

    المؤلفون: Yasir Y Elamin, Marcelo Vailati Negrao, Frank V. Fossella, Lauren Averett Byers, Jianjun Zhang, Carl Michael Gay, Janet Chen Tu, Jenny Vu Pozadzides, Hai T. Tran, Charles Lu, Lei Feng, Amy R. Spelman, George R. Blumenschein, Anne S. Tsao, John Heymach

    المصدر: Journal of Clinical Oncology. 40:9105-9105

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6bb3244b15280dbdc42a128859c999a9Test
    https://doi.org/10.1200/jco.2022.40.16_suppl.9105Test


    أضف إلى المفضلة
  9. 79
    Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib vs. Concurrent Chemoradiation Therapy in Patients With Newly Diagnosed Limited-Stage Small-Cell Lung Cancer: KEYLYNK-013

    المؤلفون: Corinne Faivre-Finn, Byoung Chul Cho, Jianxing Yu, Bin Zhao, M.C. Pietanza, Salma K. Jabbour, Andreas Rimner, L Yu, T Kato, Raffaele Califano, Lauren Averett Byers, V. Lai

    المصدر: International Journal of Radiation Oncology*Biology*Physics. 111:e468-e469

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Radiation, business.industry, Urology, Phases of clinical research, Pembrolizumab, medicine.disease, Placebo, Carboplatin, Olaparib, chemistry.chemical_compound, Oncology, chemistry, medicine, Radiology, Nuclear Medicine and imaging, Prophylactic cranial irradiation, Lung cancer, business, Etoposide, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9500ece37f6f5c6fd9e46020cac375aeTest
    https://doi.org/10.1016/j.ijrobp.2021.07.1308Test


    أضف إلى المفضلة
  10. 80
    Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

    المؤلفون: C. Allison Stewart, Carl M. Gay, Yuanxin Xi, Santhosh Sivajothi, V. Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M. Hartsfield, Veerakumar Balasubramaniyan, Milind D. Chalishazar, Cesar Moran, Neda Kalhor, John Stewart, Hai Tran, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, John de Groot, Bonnie Glisson, Trudy G. Oliver, John V. Heymach, Ignacio Wistuba, Paul Robson, Jing Wang, Lauren Averett Byers

    المصدر: Nat Cancer

    مصطلحات موضوعية: Cancer Research, Lung Neoplasms, Tumour heterogeneity, business.industry, Cell, medicine.disease, Neoplastic Cells, Circulating, Small Cell Lung Carcinoma, Article, medicine.anatomical_structure, Circulating tumor cell, Oncology, Gene expression, medicine, Cancer research, Humans, Non small cell, Treatment resistance, Neoplasm Recurrence, Local, Single-Cell Analysis, Lung cancer, business, Gene

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc9c321503209e7be0075ae4a86b984Test
    https://pubmed.ncbi.nlm.nih.gov/35121967Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث